key: cord-0829583-9iq42ig6
authors: Knoester, Marjolein; Schölvinck, Elisabeth H.; Poelman, Randy; Smit, Sylvia; Vermont, Clementien L.; Niesters, Hubert G.M.; Van Leer-Buter, Coretta C.
title: Upsurge of Enterovirus D68, the Netherlands, 2016
date: 2017-01-03
journal: Emerg Infect Dis
DOI: 10.3201/eid2301.161313
sha: 3a6f606e9489f6f9ae05e6f0a5fec50572fd0208
doc_id: 829583
cord_uid: 9iq42ig6

In June and July 2016, we identified 8 adults and 17 children with respiratory enterovirus D68 infections. Thirteen children required intensive care unit admission because of respiratory insufficiency, and 1 had concomitant acute flaccid myelitis. Phylogenetic analysis showed that all of 20 sequences obtained belong to the recently described clade B3.

T he largest enterovirus D68 (EV-D68) outbreak occurred in the United States during the summer and fall of 2014. Approximately 1,100 respiratory EV-D68 infections were recorded, mostly in children, many of whom required intensive care unit (ICU) admission. Most diseases were of respiratory nature, but concurrent with the upsurge of EV-D68, the Centers for Disease Control and Prevention (Atlanta, GA, USA) recorded 120 cases of acute flaccid myelitis (AFM) (1) . A Europewide study identified circulation of EV-D68 during the same period. Although numbers were lower, ICU admissions and 3 cases of AFM were reported (2) . Before 2014, only a few small outbreaks of EV-D68 had been described worldwide, all with respiratory infections.

Our clinical virology laboratory (University Medical Center Groningen, Groningen, the Netherlands) reported an increase of EV-D68 infections in 2010 and again in 2014, in parallel with the US outbreak (3, 4) . Very limited activity of EV-D68 was observed in 2015. Since June 2016, we have again identified a substantial increase in respiratory EV-D68 infections in our hospital, just 2 years after the previous upsurge. To raise awareness of this upsurge and the severity of EV-D68 infections, we report on 25 cases. In addition, we show the phylogenetic relationship between the 2016 EV-D68 strains and those that circulated in 2014.

The University Medical Center Groningen is a tertiary referral center in the northern part of the Netherlands. We perform routine diagnostic real-time PCR for all patients evaluated for respiratory disease by laboratory developed tests for 17 targets, including adenovirus, bocavirus, coronavirus, enterovirus, metapneumovirus, influenza, parainfluenzavirus, rhinovirus, and respiratory syncytial virus (5) . From all enterovirus detections with a cycle threshold (C t ) value <31, we sequence part of the viral protein 1 gene on a weekly basis (6) . To obtain rapid typing results in the current outbreak, a specific EV-D68 real-time PCR was also used (3), when enterovirus PCR was found positive.

We identified 3 EV-D68 infections in June and 22 additional cases in July. We found a stable seasonal variance for enterovirus and a sudden rise of enterovirus infections in July, mainly caused by EV-D68 ( Figure 1 ).

The EV-D68-positive specimens were nasopharyngeal swabs (n = 8), sputum (n = 2), and nasopharyngeal brushes (n = 15). Two viral respiratory co-infections were detected: rhinovirus A15 in patient 12 (enterovirus C t 17, rhinovirus C t 21) and parainfluenzavirus type 4 in patient 23 (enterovirus C t 14, parainfluenza virus 4 C t 31). For 20 patients, we obtained sequence results identifying EV-D68; the remaining 5 could not be typed by sequencing but were positive in our specific EV-D68 PCR.

Of the 25 patients, 8 were adults and 17 were children (Table) . In the adults, 6 of whom were transplant recipients, symptoms were mild and influenza-like. In children, however, we observed life-threatening respiratory distress, for which ICU admission was necessary for 13 (Table) . Twenty-one patients had an underlying or concurrent condition, in the children mostly pulmonary.

One child (patient 16) had the clinical characteristics of AFM. This nearly 4-year-old boy had a history of headaches for 1 week and an influenza-like illness for 3 days. He had rapidly progressing asymmetric weakness of arms and legs, bulbar paralysis, asymmetric facial paralysis, and respiratory distress for which he needed ventilatory support. Cerebrospinal fluid (CSF) analysis showed no abnormalities. Axial fluid-attenuated inversion recovery magnetic resonance imaging (MRI) showed hyperintense nonenhancing gray matter lesions in brainstem and spinal cord. Electromyography findings supported injury on the level of the motor axon or the anterior horn of the spinal cord. No varicella zoster virus, herpes simplex virus, enterovirus, or parechovirus were detected in the CSF. In the nasopharyngeal swab, only EV-D68 was detected.

All patients in this report were treated in our tertiary referral hospital, but they originated from different regions in the north of the Netherlands. Spatial epidemiology data did not suggest an epidemiologic link or outbreak (data not shown). In 2 children, EV-D68 symptoms developed >48 hours after admission; the source of possible nosocomial infection was not identified. We obtained 20 sequences of part of the EV-D68 viral protein gene and aligned them with the sequences from the 2014 epidemic. Clades were assigned as described previously (7) by the neighbor-joining method by using BioNumerics software 6.6 (Applied Maths/bioMérieux, Sint-Martens-Latem, Belgium). Sequence analysis (Figure 2) showed that the 2016 strains were closely related to sequences of the recently described subclade B3 (8), represented in Figure 2 by 4 sequences from China. The nucleotide divergence was 2.1% within B3, 5.5% between B1 and B3, and 7.3% between B2 and B3. We submitted our 20 sequences from 2016 to GenBank (accession nos. KX685066-KX685084 and KX710328).

After the upsurge of EV-D68 in our region during 2009 and 2010, we set up routine genotypic characterization for several viral pathogens, including enterovirus and rhinovirus, which is also offered to regional referring hospitals and healthcare institutions. Sequencing results are available within 1 week, which provides clinically relevant and epidemiologic information. This so-called REGIOTYPE strategy contributed to timely detection of EV-D68 in our hospital in 2014, as well as in 2016. We recognized a sudden reappearance of EV-D68 with a sharp increase of cases that could not be explained by a change in surveillance strategy.

In line with previous outbreaks, mostly children were affected, and those with underlying pulmonary conditions seemed at higher risk for ICU admission (9) . The number of children who needed ICU admission was higher in 2016 than in our 2010 and 2014 reports (3, 4) . Although dynamics of viral disease and shedding are not known for EV-D68, we assume a role for EV-D68 in the symptoms of patients 12 and 23, as, in line with rhinovirus infections, higher viral load might indicate symptomatic disease (10) .

Evidence that EV-D68 might cause AFM is increasing after recent epidemiologic investigations (1, 11, 12) . In patient 16, atypical Guillain-Barré syndrome initially was diagnosed; however, this diagnosis was later discarded because the electromyography results indicated motoric axon or anterior horn cell disease, and the clinical picture and MRI results were in favor of AFM (13) . MRI findings were subtle, and radiologic diagnosis was made only after further review and discussion of the case with the neurologists. The absence of EV-D68 in CSF is consistent with previous reports (1, 12) .

Sequencing results showed that the strains in our study cluster in the recently described clade B3 (8) . During the 2014 outbreak, most EV-D68 sequences belonged to clades B1 and B2, although A1 and A2 were also represented (2,14). Larger epidemiologic and genotyping studies are needed to evaluate whether the distinction within clade B is tenable and whether our clinical findings are typical for subclade B3.

This upsurge could indicate an active EV-D68 season, as highlighted by the epidemiologic curve, with a potential increase in AFM cases. Clinicians should be alert for EV-D68, its clinical implications, and the need for appropriate diagnostics, particularly in children who are admitted with respiratory failure to the ICU or with possible symptoms of AFM.

Acute flaccid myelitis in the United States

European surveillance for enterovirus D68 during the emerging North-American outbreak in 2014

The emergence of enterovirus D68 in a Dutch University Medical Center and the necessity for routinely screening for respiratory viruses

Upsurge of human enterovirus 68 infections in patients with severe respiratory tract infections

Role of respiratory pathogens in infants hospitalized for a first episode of wheezing and their impact on recurrences

Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens

Worldwide emergence of multiple clades of enterovirus 68

Molecular evolution and the global reemergence of enterovirus D68 by genome-wide analysis

2014 outbreak of enterovirus D68 in North America

Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values

Enterovirus D68 infection in children with acute flaccid myelitis

Acute flaccid myelitis: A clinical review of US cases 2012-2015

Council of State and Territorial Epidemiologists. Standardized case definition for acute flaccid myelitis

Epidemiological and clinical characteristics of patients infected with enterovirus D68

We thank Oebo Brouwer for his neurology expertise.Dr. Knoester is an attending physician in clinical microbiology at the Department of Medical Microbiology, University Medical Center Groningen. Her research focuses on clinical virology and epidemiology.